Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market [Seeking Alpha]
Summit Therapeutics Inc. (SMMT)
Last summit therapeutics inc. earnings: 6/12 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
summitplc.com/investors/investor-centre
Company Research
Source: Seeking Alpha
Summary Summit Therapeutics Inc. may have the successor to Merck's $25bn selling keytruda in its pipeline. Partner Akeso's data from China clinical studies shows outperformance against Merck's standard of care in NSCLC. This is no small feat — repeat this performance in US studies and Summit will have a “mega-blockbuster” on its hands/. After sensational share price gains in September, the market is more circumspect. It may be time to watch on and see how Summit's plans for US approval develop. Henrik Sorensen/DigitalVision via Getty Images Investment Overview — Summit / Akeso's Cancer Drug Shows Superiority To Keytruda — Valuation Skyrockets Summit Therapeutics Inc. NASDAQ: SMMT ) is a Miami, Florida headquartered biotech whose lead development candidate is ivonescimab, which the company If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel,
Show less
Read more
Impact Snapshot
Event Time:
SMMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SMMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SMMT alerts
High impacting Summit Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
SMMT
News
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- 2024 COO of the Year Awards - Winners Announced [Yahoo! Finance]Yahoo! Finance
- Is Summit Therapeutics a Millionaire Maker? [Yahoo! Finance]Yahoo! Finance
- Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock? [Yahoo! Finance]Yahoo! Finance
- A Memoir Of Extraordinary Resilience: The Unstoppable Power Of Love, Science, And Community To Defy The Odds [Forbes]Forbes
SMMT
Earnings
- 10/30/24 - Beat
SMMT
Sec Filings
- 1/24/25 - Form 8-K
- 1/14/25 - Form 4
- 1/13/25 - Form 8-K
- SMMT's page on the SEC website